Immunohistochemical analysis of representative cases from this cohort confirmed that MITFlow/c-JUNhigh melanomas were dedifferentiated (gp100−) and infiltrated by CD45+ immune cells that were largely CD14+ myeloid cells (Fig. 6j and Supplementary Fig. 7k). This evidence concerns the gene PTPRC and melanoma.